Portfolio Tracker
Alle Depots an einem Ort. Dein Gesamtvermögen immer im Blick, tiefgründige Renditeanalysen und Dividendenplaner.
Anzeige
EQS-News

neurocare group AG Welcomes Norman Erhard as Senior VP Europe & Latin America 05.04.2024, 09:45 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: neurocare group AG / Key word(s): Personnel
neurocare group AG Welcomes Norman Erhard as Senior VP Europe & Latin America

05.04.2024 / 09:45 CET/CEST
The issuer is solely responsible for the content of this announcement.


neurocare group AG Welcomes Norman Erhard as Senior VP Europe & Latin America

Munich, Germany, 05. April 2024 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and performance empowering clinicians to deliver best practice is pleased to announce the appointment of Norman Erhard as Senior Vice President Europe & Latin America, bolstering neurocare's Global Leadership.

Norman Erhard brings with him a distinguished career spanning over three decades in the medical devices and clinic networks sector. With a Diploma in Industrial Engineering from the Karlsruhe Institute of Technology, Norman's expertise and experience in complex medical technology and associated business development is deep. His tenure at Fresenius Medical Care saw him succeed in various key roles, where he spearheaded sales, led European marketing efforts, drove business development initiatives, and successfully managed a clinic network across Europe.

Under his leadership, the region's revenue experienced remarkable growth, reaching 550 million USD, alongside the growth of a robust workforce exceeding 4,000 employees. Norman's strategic acumen extends beyond corporate realms; he is an early investor in neurocare, reflecting his commitment to advancing healthcare innovation.

"We are thrilled to welcome Norman to the neurocare team," said Thomas Mechtersheimer, CEO of neurocare group AG. "His invaluable expertise and leadership will play a pivotal role in advancing our mission of driving innovation in personalized mental health treatments. We look forward to Norman’s contributions as we continue to empower clinicians and transform lives globally."

About neurocare group AG

neurocare is innovating mental health and performance. We offer the first digital therapy platform (DTP) in its area that empowers clinicians to deliver best practice. Our integrated and personalized therapy approach is based on a strong clinical science background with over 20 years of research and technology development. Our business is driven by two strong growth channels: building our own clinics and providing our unique DTP to third parties. neurocare currently treating on average 3.000 patients annually in our own clinics. neurocare’s scalable business is ready to meet the need for more productive and sustainable solutions. www.neurocaregroup.com

Contact:

Sally Remington
neurocare group AG
media@neurocaregroup.com



05.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


1873893  05.04.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1873893&application_name=news&site_id=boersennews
Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer